Strong news flow from two projects to potentially drive Argent higher

|

Published 31-MAR-2017 12:43 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

In providing a shareholder update on Friday morning, Argent Minerals’ (ASX:ARD) Chief Executive David Busch highlighted two key upcoming developments that have the potential to provide share price momentum. These relate to its Kempfield polymetallic operations where a resource upgrade is imminent and the West Wyalong porphyry copper-gold project.

It should be noted that any catalysts are speculative at this stage and should not be taken as guaranteed and that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

By way of background, the Kempfield project is located in New South Wales and a mineral resource of 21.8 million tonnes and 52 million ounces of silver equivalent contained metal was reported on May 2014 based on 495 drill holes.

Drilling has intersected combined lead/zinc grades of up to 17.9% immediately to the west of the existing mineral resource, and numerous high grade gold intervals including a spectacular gold intersection of 1 metre grading 1065 grams per tonne was identified at one particular drill hole.

Drilling to early 2017 has extended the potential deposit dimensions to approximately 200 metres in depth and one kilometre north-east and 800 metres south.

The Kempfield deposit is not fully defined with potentially significant additional tonnage to be added by further drilling. Management expects the planned resource update to incorporate potential lateral and depth extensions identified by recent drilling, which could nearly double the size of the existing deposit dimensions.

It could be argued that the value of this asset even prior to the resource upgrade isn’t captured in ARD’s share price given the value per resource ounce comparable to peers is circa 29 cents per ounce silver equivalent relative to the company’s closing share price on Thursday, March 30.

West Wyalong project located in prolific copper-gold region

The West Wyalong project also offers exploration upside, and ARD’s interest in the asset will increased to 70% on completion of the current drilling program. It is located in a highly prospective area of New South Wales with high profile adjacent projects being operated by Newcrest Mining, Mitsubishi-Clancy joint-venture, Sandfire Resources, Evolution Mining and St Barbara.

In fact it is only 37 kilometres from the Lake Cowal mine which was purchased by Evolution Mining for US$550 million.

ARD has a well-funded drilling program which is being supported by a $200,000 New South Wales government grant based on prospectivity, technical and financial assessment. On that note, ARD has been well supported across three projects with New South Wales government cooperative drilling funding totalling $750,000.

ARD is focusing on the Theia and Narragudgil targets at West Wyalong. The six-hole 2.3 kilometre diamond drilling program is expected to be completed by May 2017.

Management’s analysis of the geophysics indicates that the Theia target is a potentially significant porphyry copper-gold system with a strike length of up to 1.8 kilometres in the north-south direction.

As indicated below, the Narragudgil target appears to be an epithermal gold offshoot related to the Theia system.

tags

GOLD


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X